Intelligent Bio Solutions Inc.
INBS
$2.40
$0.051.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 33.26% | 18.14% | 3.27% | -1.90% | 3.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.26% | 18.14% | 3.27% | -1.90% | 3.87% |
| Cost of Revenue | 70.64% | 31.26% | 13.70% | 7.09% | -44.19% |
| Gross Profit | 7.07% | 5.82% | -7.90% | -12.54% | 161.81% |
| SG&A Expenses | 15.04% | 14.40% | 9.73% | -3.97% | -1.96% |
| Depreciation & Amortization | -1.35% | -1.77% | 1.41% | 0.55% | 9.73% |
| Other Operating Expenses | -59.64% | -95.35% | -100.48% | -92.30% | -32.39% |
| Total Operating Expenses | 13.42% | 4.23% | 0.49% | 0.67% | 2.78% |
| Operating Income | -7.80% | -0.31% | 0.36% | -1.44% | -2.47% |
| Income Before Tax | -13.17% | -5.60% | -4.32% | -4.06% | -2.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.17% | -5.60% | -4.32% | -4.06% | -2.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 16.43% | 10.63% | 7.76% | 5.87% | -2.25% |
| Net Income | -13.16% | -5.58% | -4.31% | -4.06% | -2.31% |
| EBIT | -7.80% | -0.31% | 0.36% | -1.44% | -2.47% |
| EBITDA | -8.49% | -2.01% | 0.59% | -1.64% | -1.67% |
| EPS Basic | 51.05% | 57.36% | 66.31% | 87.68% | 93.81% |
| Normalized Basic EPS | 53.61% | 59.20% | 67.52% | 87.87% | 93.72% |
| EPS Diluted | 51.08% | 57.38% | 66.32% | 87.68% | 93.81% |
| Normalized Diluted EPS | 53.61% | 59.20% | 67.52% | 87.87% | 93.72% |
| Average Basic Shares Outstanding | 138.92% | 128.88% | 161.63% | 237.08% | 415.47% |
| Average Diluted Shares Outstanding | 138.92% | 128.88% | 161.63% | 237.08% | 415.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |